(for every order > 35€)
Book written in french
The 23rd edition EUROCANCER 2010 once again provides an update on current knowledge and practices, by outlining the growing emergence of molecular biology, the characterisation of targets and target therapies in cancer management, as coverage is now provided of colorectal cancers, bronchial cancers, cancers of the upper airways, breast cancers, sarcomas and GIST, very short-term pancreas cancers and skin cancers.
Hence, logically:
the Essential Research Day is dedicated to the resistance of target therapies
the Clinical Research Day is dedicated to prognostic and predictive markers
the Radiotherapy Session is dedicated to combinations with target therapies
the Inter-Centre Seminar is dedicated to high-output molecular studies
the Clinical Biology Session is dedicated to the biology of metastases
The evolution of non-specific treatments is also significant and addressed in the following sessions: Pain Management, Support Care, Psychoanalysis and Psycho-Oncology, Nursing Day, Physical Therapists’ Day and Forum for Radiotherapy Technicians and Radiotherapists, and in the Day organised by the INCa covering the main aspects related to cervical and prostate cancer screening.